SCHEMBL5490641

SCHEMBL5490641

C=CC(=O)[N+]1(C(=O)O)CCCCC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9511727 0.88 LMNA (0.32) LMNA
SCHEMBL4362207 0.70
SCHEMBL12538032 0.69 TSHR (0.31)
Cyclohexane SCHEMBL30181158 0.65 LMNA (0.77) LMNA
Cyclopentane SCHEMBL29560097 0.65 LMNA (0.77) LMNA
Cyclopentane SCHEMBL23533982 0.65 LMNA (0.77) LMNA
Acrylic Acid SCHEMBL8851935 0.65 LMNA (0.77) LMNA
Acrylic Acid SCHEMBL31202877 0.65 LMNA (0.77) LMNA
Cyclohexane SCHEMBL29438320 0.65 LMNA (0.77) LMNA
Acrylic Acid SCHEMBL8513468 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844022-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF Hanmi Pharm. Co., Ltd. (KR) 2007-10-17 EP disclosed
WO-2006071017-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2006-07-06 WO disclosed